BILIARY ATRESIA
Clinical trials for BILIARY ATRESIA explained in plain language.
Never miss a new study
Get alerted when new BILIARY ATRESIA trials appear
Sign up with your email to follow new studies for BILIARY ATRESIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug may help kids with rare liver disease avoid transplant
Disease control ENROLLING_BY_INVITATIONThis study tests a drug called odevixibat in 180 children with biliary atresia, a rare liver disease. The goal is to see if the drug helps children stay alive without needing a liver transplant over the long term. Children who completed a previous study can join this open-label e…
Matched conditions: BILIARY ATRESIA
Phase: PHASE3 • Sponsor: Albireo, an Ipsen Company • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Could this pill help kids with biliary atresia skip a liver transplant?
Disease control OngoingThis Phase 3 study tests odevixibat, a daily pill, in 254 children with biliary atresia who recently had Kasai surgery. The goal is to see if the drug can prevent the need for a liver transplant or death. Children take either odevixibat or a placebo for up to 2 years, and researc…
Matched conditions: BILIARY ATRESIA
Phase: PHASE3 • Sponsor: Albireo, an Ipsen Company • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC